GILD

Gilead Sciences, Inc. News Headlines

$107.99
*  
1.90
1.79%
Get GILD Alerts
*Delayed - data as of Oct. 23, 2014 13:55 ET  -  Find a broker to begin trading GILD now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    GILD Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By
FDA Okays Gilead''s Hepatitis C Drug Harvoni
10/10/2014 2:06:00 PM - RTT News


Press Release: FDA Approves First Combination Pill to Treat Hepatitis C
10/10/2014 1:59:00 PM - Dow Jones Business News


Apple And Gilead: 2 Ballasts In A Fast Sinking Market
10/10/2014 1:24:00 PM - Seeking Alpha


Gilead's October Events Should Drive The Stock To The Next Leg Of Consolidation
10/10/2014 11:21:00 AM - Seeking Alpha


Why Gilead Is A Perfect 10
10/10/2014 9:19:00 AM - Seeking Alpha


Making Money With Charles Payne: 10/08/14
10/9/2014 6:00:00 PM - Fox Business


Can Arrowhead Research Corp. Stock Recover from Its Horrendous Drop?
10/9/2014 5:09:02 PM - Motley Fool


After Hours Most Active for Oct 9, 2014 : SIRI, SVU, BNDX, BRK/B, BAC, SYF, COG, CS, QQQ, AAPL, MSFT, GILD
10/9/2014 4:44:48 PM - NASDAQ.com News


Bristol-Myers Co Regroups; Hepatitis C Fight With Gilead Sciences Not Over
10/9/2014 12:03:02 PM - Motley Fool


Playing This Yo-Yo Market
10/9/2014 11:23:00 AM - Seeking Alpha


iShares U.S. Healthcare ETF Experiences Big Inflow
10/9/2014 11:05:17 AM - BNK Invest


3 Stocks to Buy if the Market Crashes
10/9/2014 10:31:40 AM - Motley Fool


Portfolio Changes For The Third Quarter 2014
10/9/2014 9:14:00 AM - Seeking Alpha


Bristol-Myers Gives Up on US Approval of 2-Drug HCV Combo - Analyst Blog
10/8/2014 6:10:00 PM - Zacks.com


After Hours Most Active for Oct 8, 2014 : AA, REXX, QQQ, CS, GPS, CX, ABB, KMI, ZNGA, GILD, SIRI, MSFT
10/8/2014 4:44:53 PM - NASDAQ.com News


Bristol-Myers Tells Gilead Sciences, Inc. "You Win"
10/8/2014 11:05:02 AM - Motley Fool


Called Strike 3 For Bristol-Myers Squibb: What This Says For Gilead And Its Competitors In The Hep C Market
10/8/2014 10:51:00 AM - Seeking Alpha


ETF Outlook: Health Care Select Sector SPDR ETF (XLV)
10/8/2014 9:26:45 AM - Marc Chaikin


Biotech Stock Roundup: Sunesis Tanks on Study Results, Chimerix Up on Ebola Update - Analyst Blog
10/8/2014 8:14:00 AM - Zacks.com


Gilead Sciences: Hitch Your Wagon To This Biotech Juggernaut Before It Really Takes Off
10/7/2014 7:09:00 PM - Seeking Alpha


Comparing America's 2 Largest Biotechnology Companies
10/7/2014 1:57:00 PM - Seeking Alpha


It Is Getting Ugly Out There
10/7/2014 12:16:00 PM - Seeking Alpha


The Most Important Number You Need to Know Before Buying Gilead Sciences Inc. Stock
10/7/2014 11:05:02 AM - Motley Fool


A Professor Plans His Own EnDOWment Fund For Retirement
10/7/2014 9:58:00 AM - Seeking Alpha


HCV: The 'C' Stands For Cure
10/7/2014 1:31:00 AM - Seeking Alpha